Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study (Q28242324)
Jump to navigation
Jump to search
scientific article (publication date: October 2007)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study |
scientific article (publication date: October 2007) |
Statements
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study (English)
0 references
1 October 2007
0 references
46
0 references
2
0 references
125-33
0 references